In an encouraging development, two FDA advisory panels unanimously agreed to recommend the approval of Opill (generic name: norgestrel), an over-the-counter (OTC) birth control pill. While the FDA makes its final decision, the possible consequences of over-the-counter birth control tablets are Read More...